Exclusive: In $1B+ bet on AI, biopharma heavyweights back new startup to upend drug R&D
A star-studded mix of venture capitalists and scientists, backed by more than a billion dollars, is launching an ambitious biotech that aims to reinvent drug R&D using artificial intelligence, the group exclusively told Endpoints News. The company, Xaira Therapeutics, is one of this year’s most richly funded new companies, not